|
Current Issue: September 2008
Chief Medical Editor's Page
Ted E. Feldman, MD, FSCAI
NEWS
Regulatory Update
Literature Highlights
Industry News
NEW TECHNOLOGY
Reducing Door-to-Balloon Times With Medical Simulation
By Mark A. Turco, MD, FSCAI, FACC, and Amy L. Ketron, RN, BSN
COVER STORY
Xience V (Promus) Drug-Eluting Coronary Stent
By Krishna Sudhir, MD, PhD, FRACP, FACC; David R. Rutledge, Pharm D, FAHA, FCCP; Alena Pechonkina, MD; and Chuck Simonton, MD, FACC, FSCAI
Taxus Clinical Update
By Mark A. Turco, MD, FSCAI, FACC, and Eberhard Grube, MD, FSCAI, FACC
Sirolimus-Eluting Cypher Stent
By Colin M. Barker, MD, and David E. Kandzari, MD
Clinical Trial Update on the Endeavor Stent
By Ajay J. Kirtane, MD, SM; Marcos Valerio, BS; and Martin B. Leon, MD
Stent Thrombosis in BMS and DES
By Mitchell W. Krucoff, MD, FACC
Stent Pipeline
By Alexandre Abizaid, MD, PhD; Andre Lima Brito, MD; and J. Ribamar Costa, Jr, MD
FDA INSIGHTS
2008 FDA Guidelines for DES
By Andrew Farb, MD, and Ashley B. Boam, MS
DEPARTMENTS
Innovations
Conference Calendar
An Interview With Jeffrey W. Moses, MD
|